Show
Sort by
-
Abscopal effect in metastatic renal cell carcinoma
-
Fulvestrant (Faslodex (TM)) in advanced breast cancer: clinical experience from a Belgian cooperative study
-
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
-
Fulvestrant in heavily pretreated patients with advanced breast cancer: a Belgium cooperative study.
-
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer